Alliancebernstein L.P. Pfizer Inc Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 6,665,688 shares of PFE stock, worth $187 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,665,688

Previous 6,751,375 1.27%

Holding current value

$187 Million

Previous $194 Million 4.84%

% of portfolio

0.07%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $2.22 Million - $2.55 Million	-85,687 Reduced 1.27%	6,665,688 $185 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $23.8 Million - $30.9 Million	-911,033 Reduced 11.89%	6,751,375 $194 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $66.3 Million - $77.4 Million	-2,064,775 Reduced 21.23%	7,662,408 $254 Million
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $72.4 Million - $83.8 Million	-2,005,163 Reduced 17.09%	9,727,183 $357 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $165 Million - $215 Million	-4,201,098 Reduced 26.37%	11,732,346 $479 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $31.4 Million - $40.9 Million	-751,050 Reduced 4.5%	15,933,444 $817 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $54.8 Million - $66.8 Million	-1,251,195 Reduced 6.98%	16,684,494 $730 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $27.6 Million - $32.7 Million	592,899 Added 3.42%	17,935,689 $940 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $57.9 Million - $71.7 Million	1,264,885 Added 7.87%	17,342,790 $898 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $27 Million - $40.1 Million	654,442 Added 4.24%	16,077,905 $949 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $125 Million - $160 Million	3,176,236 Added 25.93%	15,423,463 $663 Million
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $8.58 Million - $9.72 Million	238,897 Added 1.99%	12,247,227 $480 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $30 Million - $33.8 Million	-895,242 Reduced 6.94%	12,008,330 $435 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $185 Million - $235 Million	-5,513,690 Reduced 29.94%	12,903,572 $475 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $121 Million - $142 Million	-3,818,907 Reduced 17.17%	18,417,262 $676 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $63.2 Million - $76.6 Million	-2,097,571 Reduced 8.62%	22,236,169 $727 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $64.6 Million - $92.2 Million	-2,388,186 Reduced 8.94%	24,333,740 $794 Million
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $61.1 Million - $69.3 Million	1,855,884 Added 7.46%	26,721,926 $1.05 Billion
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $110 Million - $143 Million	-3,383,611 Reduced 11.98%	24,866,042 $893 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $13.6 Million - $15.3 Million	-367,425 Reduced 1.28%	28,249,653 $1.22 Billion
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $37.9 Million - $41.6 Million	1,010,676 Added 3.66%	28,617,078 $1.22 Billion
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $183 Million - $208 Million	4,749,943 Added 20.78%	27,606,402 $1.21 Billion
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $39.1 Million - $47.4 Million	1,133,623 Added 5.22%	22,856,459 $1.01 Billion
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $1.66 Million - $1.77 Million	50,301 Added 0.23%	21,722,836 $788 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $51.3 Million - $59.5 Million	1,606,384 Added 8.01%	21,672,535 $769 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $2.75 Million - $2.92 Million	82,727 Added 0.41%	20,066,151 $727 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $619 Million - $682 Million	19,983,424	19,983,424 $713 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Pfizer Inc Transaction History